 | • レポートコード：D005-16262 • 出版社/出版日：GlobalInfoResearch / 2020年5月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ワクチンアジュバントの世界市場を広く調査・分析し、今後の市場展望をまとめております。ワクチンアジュバントの種類別市場規模（経口、皮下、筋肉内、その他）、用途別市場規模（獣医XXX（研究用、商業用）、人間XXX（研究用、商業用）、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）： ・地域別グローバル市場分析 2015年-2020年 ・ワクチンアジュバントの北米市場（アメリカ、カナダ、メキシコ） ・ワクチンアジュバントのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ワクチンアジュバントのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ワクチンアジュバントの南米市場（ブラジル、アルゼンチン） ・ワクチンアジュバントの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、皮下、筋肉内、その他 ・用途別分析：獣医XXX（研究用、商業用）、人間XXX（研究用、商業用）、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Summary
Market Overview
The global Vaccine Adjuvants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1025.1 million by 2025, from USD 706.3 million in 2019.
The Vaccine Adjuvants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Vaccine Adjuvants market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Vaccine Adjuvants market has been segmented into Oral, Subcutaneous, Intramuscular, Others, etc.
By Application, Vaccine Adjuvants has been segmented into Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications), Human Vaccine Adjuvants (Research Applications, Commercial Applications), etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Vaccine Adjuvants market presented in the report. This section sheds light on the sales growth of different regional and country-level Vaccine Adjuvants markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Vaccine Adjuvants market.
The report offers in-depth assessment of the growth and other aspects of the Vaccine Adjuvants market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Vaccine Adjuvants markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Vaccine Adjuvants Market Share Analysis
Vaccine Adjuvants competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Vaccine Adjuvants sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Vaccine Adjuvants sales, revenue and market share for each player covered in this report.
The major players covered in Vaccine Adjuvants are: SEPPIC, Zhuoyue, SPI Pharma, SDA BIO, Novavax, Croda International Plc, GSK, Tj Kaiwei, Phibro Animal Health Corporation, Aphios, Novavax, CSL Limited, Avanti Polar Lipids, SPI Pharma, Brenntag Biosector, Aphios, SEPPIC, etc. Among other players domestic and global, Vaccine Adjuvants market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Adjuvants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccine Adjuvants, with price, sales, revenue and global market share of Vaccine Adjuvants in 2018 and 2019.
Chapter 3, the Vaccine Adjuvants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Vaccine Adjuvants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccine Adjuvants Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccine Adjuvants Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
1.3.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Overview of Global Vaccine Adjuvants Market
1.4.1 Global Vaccine Adjuvants Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 SEPPIC
2.1.1 SEPPIC Details
2.1.2 SEPPIC Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 SEPPIC SWOT Analysis
2.1.4 SEPPIC Product and Services
2.1.5 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Zhuoyue
2.2.1 Zhuoyue Details
2.2.2 Zhuoyue Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Zhuoyue SWOT Analysis
2.2.4 Zhuoyue Product and Services
2.2.5 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 SPI Pharma
2.3.1 SPI Pharma Details
2.3.2 SPI Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 SPI Pharma SWOT Analysis
2.3.4 SPI Pharma Product and Services
2.3.5 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 SDA BIO
2.4.1 SDA BIO Details
2.4.2 SDA BIO Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 SDA BIO SWOT Analysis
2.4.4 SDA BIO Product and Services
2.4.5 SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novavax
2.5.1 Novavax Details
2.5.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novavax SWOT Analysis
2.5.4 Novavax Product and Services
2.5.5 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Croda International Plc
2.6.1 Croda International Plc Details
2.6.2 Croda International Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Croda International Plc SWOT Analysis
2.6.4 Croda International Plc Product and Services
2.6.5 Croda International Plc Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Tj Kaiwei
2.8.1 Tj Kaiwei Details
2.8.2 Tj Kaiwei Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Tj Kaiwei SWOT Analysis
2.8.4 Tj Kaiwei Product and Services
2.8.5 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Phibro Animal Health Corporation
2.9.1 Phibro Animal Health Corporation Details
2.9.2 Phibro Animal Health Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Phibro Animal Health Corporation SWOT Analysis
2.9.4 Phibro Animal Health Corporation Product and Services
2.9.5 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aphios
2.10.1 Aphios Details
2.10.2 Aphios Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Aphios SWOT Analysis
2.10.4 Aphios Product and Services
2.10.5 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novavax
2.11.1 Novavax Details
2.11.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novavax SWOT Analysis
2.11.4 Novavax Product and Services
2.11.5 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 CSL Limited
2.12.1 CSL Limited Details
2.12.2 CSL Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 CSL Limited SWOT Analysis
2.12.4 CSL Limited Product and Services
2.12.5 CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Avanti Polar Lipids
2.13.1 Avanti Polar Lipids Details
2.13.2 Avanti Polar Lipids Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Avanti Polar Lipids SWOT Analysis
2.13.4 Avanti Polar Lipids Product and Services
2.13.5 Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 SPI Pharma
2.14.1 SPI Pharma Details
2.14.2 SPI Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 SPI Pharma SWOT Analysis
2.14.4 SPI Pharma Product and Services
2.14.5 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Brenntag Biosector
2.15.1 Brenntag Biosector Details
2.15.2 Brenntag Biosector Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Brenntag Biosector SWOT Analysis
2.15.4 Brenntag Biosector Product and Services
2.15.5 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Aphios
2.16.1 Aphios Details
2.16.2 Aphios Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Aphios SWOT Analysis
2.16.4 Aphios Product and Services
2.16.5 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 SEPPIC
2.17.1 SEPPIC Details
2.17.2 SEPPIC Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 SEPPIC SWOT Analysis
2.17.4 SEPPIC Product and Services
2.17.5 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Vaccine Adjuvants Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Vaccine Adjuvants Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Vaccine Adjuvants Manufacturer Market Share in 2019
3.3.2 Top 6 Vaccine Adjuvants Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Regions
4.1.1 Global Vaccine Adjuvants Sales and Market Share by Regions (2015-2020)
4.1.2 Global Vaccine Adjuvants Revenue and Market Share by Regions (2015-2020)
4.2 North America Vaccine Adjuvants Sales and Growth Rate (2015-2020)
4.3 Europe Vaccine Adjuvants Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Vaccine Adjuvants Sales and Growth Rate (2015-2020)
4.5 South America Vaccine Adjuvants Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Vaccine Adjuvants Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Vaccine Adjuvants Sales, Revenue and Market Share by Country
5.1.1 North America Vaccine Adjuvants Sales and Market Share by Country (2015-2020)
5.1.2 North America Vaccine Adjuvants Revenue and Market Share by Country (2015-2020)
5.2 United States Vaccine Adjuvants Sales and Growth Rate (2015-2020)
5.3 Canada Vaccine Adjuvants Sales and Growth Rate (2015-2020)
5.4 Mexico Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Vaccine Adjuvants Sales, Revenue and Market Share by Country
6.1.1 Europe Vaccine Adjuvants Sales and Market Share by Country (2015-2020)
6.1.2 Europe Vaccine Adjuvants Revenue and Market Share by Country (2015-2020)
6.2 Germany Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6.3 UK Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6.4 France Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6.5 Russia Vaccine Adjuvants Sales and Growth Rate (2015-2020)
6.6 Italy Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Vaccine Adjuvants Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Vaccine Adjuvants Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Vaccine Adjuvants Revenue and Market Share by Regions (2015-2020)
7.2 China Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.3 Japan Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.4 Korea Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.5 India Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Vaccine Adjuvants Sales and Growth Rate (2015-2020)
7.7 Australia Vaccine Adjuvants Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Vaccine Adjuvants Sales, Revenue and Market Share by Country
8.1.1 South America Vaccine Adjuvants Sales and Market Share by Country (2015-2020)
8.1.2 South America Vaccine Adjuvants Revenue and Market Share by Country (2015-2020)
8.2 Brazil Vaccine Adjuvants Sales and Growth Rate (2015-2020)
8.3 Argentina Vaccine Adjuvants Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Vaccine Adjuvants Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Vaccine Adjuvants Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Vaccine Adjuvants Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Vaccine Adjuvants Sales and Growth Rate (2015-2020)
9.3 Turkey Vaccine Adjuvants Sales and Growth Rate (2015-2020)
9.4 Egypt Vaccine Adjuvants Sales and Growth Rate (2015-2020)
9.5 South Africa Vaccine Adjuvants Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Vaccine Adjuvants Sales and Market Share by Type (2015-2020)
10.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2015-2020)
10.3 Global Vaccine Adjuvants Price by Type (2015-2020)
11 Global Vaccine Adjuvants Market Segment by Application
11.1 Global Vaccine Adjuvants Sales Market Share by Application (2015-2020)
11.2 Global Vaccine Adjuvants Revenue Market Share by Application (2015-2020)
11.3 Global Vaccine Adjuvants Price by Application (2015-2020)
12 Market Forecast
12.1 Global Vaccine Adjuvants Sales, Revenue and Growth Rate (2021-2025)
12.2 Vaccine Adjuvants Market Forecast by Regions (2021-2025)
12.2.1 North America Vaccine Adjuvants Market Forecast (2021-2025)
12.2.2 Europe Vaccine Adjuvants Market Forecast (2021-2025)
12.2.3 Asia-Pacific Vaccine Adjuvants Market Forecast (2021-2025)
12.2.4 South America Vaccine Adjuvants Market Forecast (2021-2025)
12.2.5 Middle East & Africa Vaccine Adjuvants Market Forecast (2021-2025)
12.3 Vaccine Adjuvants Market Forecast by Type (2021-2025)
12.3.1 Global Vaccine Adjuvants Sales Forecast by Type (2021-2025)
12.3.2 Global Vaccine Adjuvants Market Share Forecast by Type (2021-2025)
12.4 Vaccine Adjuvants Market Forecast by Application (2021-2025)
12.4.1 Global Vaccine Adjuvants Sales Forecast by Application (2021-2025)
12.4.2 Global Vaccine Adjuvants Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Vaccine Adjuvants Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Vaccine Adjuvants Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. SEPPIC Basic Information, Manufacturing Base and Competitors
Table 8. SEPPIC Vaccine Adjuvants Major Business
Table 9. SEPPIC Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 10. SEPPIC SWOT Analysis
Table 11. SEPPIC Vaccine Adjuvants Product and Services
Table 12. SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Zhuoyue Basic Information, Manufacturing Base and Competitors
Table 14. Zhuoyue Vaccine Adjuvants Major Business
Table 15. Zhuoyue Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 16. Zhuoyue SWOT Analysis
Table 17. Zhuoyue Vaccine Adjuvants Product and Services
Table 18. Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. SPI Pharma Basic Information, Manufacturing Base and Competitors
Table 20. SPI Pharma Vaccine Adjuvants Major Business
Table 21. SPI Pharma Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 22. SPI Pharma SWOT Analysis
Table 23. SPI Pharma Vaccine Adjuvants Product and Services
Table 24. SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. SDA BIO Basic Information, Manufacturing Base and Competitors
Table 26. SDA BIO Vaccine Adjuvants Major Business
Table 27. SDA BIO Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 28. SDA BIO SWOT Analysis
Table 29. SDA BIO Vaccine Adjuvants Product and Services
Table 30. SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novavax Basic Information, Manufacturing Base and Competitors
Table 32. Novavax Vaccine Adjuvants Major Business
Table 33. Novavax Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 34. Novavax SWOT Analysis
Table 35. Novavax Vaccine Adjuvants Product and Services
Table 36. Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Croda International Plc Basic Information, Manufacturing Base and Competitors
Table 38. Croda International Plc Vaccine Adjuvants Major Business
Table 39. Croda International Plc Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 40. Croda International Plc SWOT Analysis
Table 41. Croda International Plc Vaccine Adjuvants Product and Services
Table 42. Croda International Plc Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GSK Basic Information, Manufacturing Base and Competitors
Table 44. GSK Vaccine Adjuvants Major Business
Table 45. GSK Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 46. GSK SWOT Analysis
Table 47. GSK Vaccine Adjuvants Product and Services
Table 48. GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Tj Kaiwei Basic Information, Manufacturing Base and Competitors
Table 50. Tj Kaiwei Vaccine Adjuvants Major Business
Table 51. Tj Kaiwei Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 52. Tj Kaiwei SWOT Analysis
Table 53. Tj Kaiwei Vaccine Adjuvants Product and Services
Table 54. Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Phibro Animal Health Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Phibro Animal Health Corporation Vaccine Adjuvants Major Business
Table 57. Phibro Animal Health Corporation Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 58. Phibro Animal Health Corporation SWOT Analysis
Table 59. Phibro Animal Health Corporation Vaccine Adjuvants Product and Services
Table 60. Phibro Animal Health Corporation Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Aphios Basic Information, Manufacturing Base and Competitors
Table 62. Aphios Vaccine Adjuvants Major Business
Table 63. Aphios Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 64. Aphios SWOT Analysis
Table 65. Aphios Vaccine Adjuvants Product and Services
Table 66. Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Novavax Basic Information, Manufacturing Base and Competitors
Table 68. Novavax Vaccine Adjuvants Major Business
Table 69. Novavax Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 70. Novavax SWOT Analysis
Table 71. Novavax Vaccine Adjuvants Product and Services
Table 72. Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 74. CSL Limited Vaccine Adjuvants Major Business
Table 75. CSL Limited Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 76. CSL Limited SWOT Analysis
Table 77. CSL Limited Vaccine Adjuvants Product and Services
Table 78. CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
Table 80. Avanti Polar Lipids Vaccine Adjuvants Major Business
Table 81. Avanti Polar Lipids Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 82. Avanti Polar Lipids SWOT Analysis
Table 83. Avanti Polar Lipids Vaccine Adjuvants Product and Services
Table 84. Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. SPI Pharma Basic Information, Manufacturing Base and Competitors
Table 86. SPI Pharma Vaccine Adjuvants Major Business
Table 87. SPI Pharma Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 88. SPI Pharma SWOT Analysis
Table 89. SPI Pharma Vaccine Adjuvants Product and Services
Table 90. SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table 92. Brenntag Biosector Vaccine Adjuvants Major Business
Table 93. Brenntag Biosector Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 94. Brenntag Biosector SWOT Analysis
Table 95. Brenntag Biosector Vaccine Adjuvants Product and Services
Table 96. Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Aphios Basic Information, Manufacturing Base and Competitors
Table 98. Aphios Vaccine Adjuvants Major Business
Table 99. Aphios Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 100. Aphios SWOT Analysis
Table 101. Aphios Vaccine Adjuvants Product and Services
Table 102. Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. SEPPIC Basic Information, Manufacturing Base and Competitors
Table 104. SEPPIC Vaccine Adjuvants Major Business
Table 105. SEPPIC Vaccine Adjuvants Total Revenue (USD Million) (2017-2018)
Table 106. SEPPIC SWOT Analysis
Table 107. SEPPIC Vaccine Adjuvants Product and Services
Table 108. SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global Vaccine Adjuvants Sales by Manufacturer (2018-2019) (Kg)
Table 110. Global Vaccine Adjuvants Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global Vaccine Adjuvants Sales by Regions (2015-2020) (Kg)
Table 112. Global Vaccine Adjuvants Sales Market Share by Regions (2015-2020)
Table 113. Global Vaccine Adjuvants Revenue by Regions (2015-2020) (USD Million)
Table 114. North America Vaccine Adjuvants Sales by Countries (2015-2020) (Kg)
Table 115. North America Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Table 116. North America Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million)
Table 117. North America Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Table 118. Europe Vaccine Adjuvants Sales by Countries (2015-2020) (Kg)
Table 119. Europe Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Table 120. Europe Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific Vaccine Adjuvants Sales by Regions (2015-2020) (Kg)
Table 122. Asia-Pacific Vaccine Adjuvants Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific Vaccine Adjuvants Revenue by Regions (2015-2020) (USD Million)
Table 124. South America Vaccine Adjuvants Sales by Countries (2015-2020) (Kg)
Table 125. South America Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Table 126. South America Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million)
Table 127. South America Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa Vaccine Adjuvants Sales by Countries (2015-2020) (Kg)
Table 129. Middle East & Africa Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa Vaccine Adjuvants Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Table 132. Global Vaccine Adjuvants Sales by Type (2015-2020) (Kg)
Table 133. Global Vaccine Adjuvants Sales Share by Type (2015-2020)
Table 134. Global Vaccine Adjuvants Revenue by Type (2015-2020) (USD Million)
Table 135. Global Vaccine Adjuvants Revenue Share by Type (2015-2020)
Table 136. Global Vaccine Adjuvants Sales by Application (2015-2020) (Kg)
Table 137. Global Vaccine Adjuvants Sales Share by Application (2015-2020)
Table 138. Global Vaccine Adjuvants Sales Forecast by Regions (2021-2025) (Kg)
Table 139. Global Vaccine Adjuvants Market Share Forecast by Regions (2021-2025)
Table 140. Global Vaccine Adjuvants Sales Forecast by Type (2021-2025) (Kg)
Table 141. Global Vaccine Adjuvants Market Share Forecast by Type (2021-2025)
Table 142. Global Vaccine Adjuvants Sales Forecast by Application (2021-2025)
Table 143. Global Vaccine Adjuvants Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Vaccine Adjuvants Picture
Figure 2. Global Sales Market Share of Vaccine Adjuvants by Type in 2019
Figure 3. Oral Picture
Figure 4. Subcutaneous Picture
Figure 5. Intramuscular Picture
Figure 6. Others Picture
Figure 7. Vaccine Adjuvants Sales Market Share by Application in 2018
Figure 8. Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure 9. Human Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure 10. Global Vaccine Adjuvants Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Vaccine Adjuvants Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Vaccine Adjuvants Sales Market Share by Manufacturer in 2019
Figure 31. Global Vaccine Adjuvants Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 36. Global Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Vaccine Adjuvants Revenue Market Share by Regions (2015-2020)
Figure 38. Global Vaccine Adjuvants Revenue Market Share by Regions in 2018
Figure 39. North America Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 40. Europe Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 42. South America Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Vaccine Adjuvants Sales and Growth Rate (2015-2020)
Figure 44. North America Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Vaccine Adjuvants Sales Market Share by Countries (2015-2020)
Figure 46. North America Vaccine Adjuvants Sales Market Share by Countries in 2018
Figure 47. North America Vaccine Adjuvants Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Vaccine Adjuvants Revenue Market Share by Countries in 2018
Figure 49. United States Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 50. Canada Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 51. Mexico Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 52. Europe Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Vaccine Adjuvants Revenue Market Share by Countries in 2019
Figure 55. Germany Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 56. UK Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 57. France Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 58. Russia Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 59. Italy Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 60. Asia-Pacific Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Vaccine Adjuvants Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Vaccine Adjuvants Revenue Market Share by Regions 2019
Figure 63. China Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 64. Japan Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 65. Korea Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 66. India Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 67. Southeast Asia Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 68. South America Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Vaccine Adjuvants Sales Market Share by Countries in 2019
Figure 70. South America Vaccine Adjuvants Revenue Market Share by Countries in 2019
Figure 71. Brazil Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 72. Argentina Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 73. Middle East and Africa Vaccine Adjuvants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Vaccine Adjuvants Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 78. Egypt Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 79. Turkey Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 80. South Africa Vaccine Adjuvants Sales and Growth Rate (2015-2020) (Kg)
Figure 81. Global Vaccine Adjuvants Sales and Growth Rate (2021-2025) (Kg)
Figure 82. Global Vaccine Adjuvants Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Vaccine Adjuvants Market Forecast (2021-2025) (Kg)
Figure 84. Europe Sales Vaccine Adjuvants Market Forecast (2021-2025) (Kg)
Figure 85. Asia-Pacific Sales Vaccine Adjuvants Market Forecast (2021-2025) (Kg)
Figure 86. South America Sales Vaccine Adjuvants Market Forecast (2021-2025) (Kg)
Figure 87. Middle East & Africa Sales Vaccine Adjuvants Market Forecast (2021-2025) (Kg)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
アジュバントの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Adjuvants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Adjuvants market report provides a …- 農業用補助剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Agriculture Adjuvants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3761.2 million by 2025, from USD 3163.9 million in 2019. The Agriculture Ad…
- ヒト用予防ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Prophylactic Human Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prophylactic Human…
- 経口ロタウイルスワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Rotavirus Vaccine…
- 麻疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Measle Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Measle Vaccine market report p…